Jim Cramer's Latest Post

How to Decide What to Buy

More Trading Strategies

By

James "Rev Shark" DePorre

 | Jul 31, 2014 | 5:10 PM EDT |
The key to this action is to guard against getting hit too hard in the near term.
By

Daniel Dicker

 | Jul 31, 2014 | 5:00 PM EDT |
My guess is that it will be relatively shallow but take a rather long time.
By

Jim Cramer

 | Jul 31, 2014 | 4:04 PM EDT |
Opportunites are difficult to find, but patience will still be rewarded.
By

Tim Melvin

 | Jul 31, 2014 | 4:00 PM EDT |
The whole sector's valuation is fueled on hopes and dreams. 
By

Kate Stalter

 | Jul 31, 2014 | 3:00 PM EDT |
Remember that whenever you buy or sell a stock, they take a cut.
By

Mike Norman

 | Jul 31, 2014 | 2:00 PM EDT |
A Fed rate hike would not crush stocks, and it would not drive up the cost of funding.
By

Jim Cramer

 | Jul 31, 2014 | 1:37 PM EDT |
Is the high price worth it if you believe in management?
By

Sham Gad

 | Jul 31, 2014 | 1:00 PM EDT |
Growth can be deceptive, and that's where investors get into trouble.
By

Doug Kass

 | Jul 31, 2014 | 12:30 PM EDT |
A lot of things need to go well for the power of free to pay out all that it is promising. 
By

Jared Dillian

 | Jul 31, 2014 | 12:00 PM EDT |
It feels like we are living on borrowed time.
By

Brian Sozzi

 | Jul 31, 2014 | 11:00 AM EDT |
There's a lot to like here -- but it does remains a show-me story.
By

Eric Jackson

 | Jul 31, 2014 | 10:17 AM EDT |
It can still boost revenues, but the product side is problematic.
By

Chris Versace and Lenore Hawkins

 | Jul 31, 2014 | 10:00 AM EDT |
The pattern looks clear in stocks, bonds and sovereign debt.
By

Gary Berman

 | Jul 31, 2014 | 9:41 AM EDT |
If the S&P closes below 1960.23, July will officially be a down month -- but it takes time for tops to form.
By

Bret Jensen

 | Jul 31, 2014 | 9:30 AM EDT |
Here are a few stocks I have made solid calls on recently that have moved up.

Upgrades & Downgrades

Bullish
Jul 31, 2014 | 8:32 AM EDT
Shares of HES now seen reaching $120, according to Credit Suisse. Estimates also upped, as the Bakken should continue to drive growth. …
Bullish
Jul 31, 2014 | 8:29 AM EDT
BAH was upgraded from Neutral to Outperform, Credit Suisse said. $27 price target. Company is keeping a tight lid on costs and returnin…
Jul 31, 2014 | 8:28 AM EDT
OTEX was upgraded from Neutral to Outperform, Credit Suisse said. $65 price target. Estimates also increased, as the new product cycle …
Jul 31, 2014 | 8:27 AM EDT
AKAM estimates were boosted through 2015, Piper Jaffray said. Company is seeing higher growth in both media/performance and security. O…
Bullish
Jul 31, 2014 | 8:25 AM EDT
X price target raised from $31 to $35, Jefferies said. Hold rating. Estimates also raised due to lower costs and stable pricing.
Volume in the SPY today was nearly double its 50 day average of volume. (The graph at the ...
Is this the biotech revolution or the biotech bust? View Small Cap Biotechs Like Never Bef...
Market got beat like a rented mule today as equities posted their second worst day of the ...

down 302 now, at 16577 the dow 30 is unchanged for 2014. roll the media hype!

REAL MONEY PRO'S BEST IDEAS

Columnist Tweets

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.